Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
03 12 2019
Historique:
received: 28 06 2019
revised: 20 08 2019
accepted: 17 10 2019
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 29 9 2020
Statut: ppublish

Résumé

Broadly HIV-1 neutralizing VRC01 class antibodies target the CD4-binding site of Env. They are derived from VH1-2

Identifiants

pubmed: 31801073
pii: S2211-1247(19)31393-2
doi: 10.1016/j.celrep.2019.10.071
pmc: PMC6936959
mid: NIHMS1545816
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Neutralizing 0
Broadly Neutralizing Antibodies 0
CD4 Antigens 0
HIV Antibodies 0
Immunoglobulin Heavy Chains 0
Polysaccharides 0
Receptors, Antigen, B-Cell 0
VRC01 monoclonal antibody 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3060-3072.e7

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM120553
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109632
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104384
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI138212
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Elife. 2016 Nov 15;5:
pubmed: 27845625
Cell. 2016 Sep 8;166(6):1471-1484.e18
pubmed: 27610571
Science. 2016 Mar 25;351(6280):1458-63
pubmed: 27013733
PLoS Pathog. 2013 Jan;9(1):e1003106
pubmed: 23300456
Science. 2013 May 10;340(6133):711-6
pubmed: 23539181
J Exp Med. 2017 Sep 4;214(9):2573-2590
pubmed: 28847869
Infect Immun. 2008 Aug;76(8):3817-23
pubmed: 18474650
Cell. 2015 Jun 18;161(7):1505-15
pubmed: 26091035
Cell Rep. 2016 Nov 1;17(6):1560-1570
pubmed: 27806295
J Struct Biol. 2009 Apr;166(1):95-102
pubmed: 19263523
J Struct Biol. 1999 Dec 1;128(1):82-97
pubmed: 10600563
Nature. 2019 Jun;570(7762):468-473
pubmed: 31142836
Cell. 2016 Sep 8;166(6):1459-1470.e11
pubmed: 27610570
J Proteome Res. 2013 Mar 1;12(3):1520-5
pubmed: 23347405
Curr Protoc Bioinformatics. 2012 Dec;Chapter 13:Unit13.20
pubmed: 23255153
Cell Rep. 2017 Dec 5;21(10):2992-3002
pubmed: 29212041
J Mol Biol. 2012 Jan 13;415(2):406-18
pubmed: 22100448
Sci Transl Med. 2018 Jul 4;10(448):
pubmed: 29973404
J Struct Biol. 2009 May;166(2):205-13
pubmed: 19374019
Science. 2011 Sep 16;333(6049):1593-602
pubmed: 21835983
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Cell. 2015 Jun 4;161(6):1280-92
pubmed: 26004070
Methods Mol Biol. 2009;485:395-405
pubmed: 19020839
J Immunol Methods. 2009 Oct 31;350(1-2):183-93
pubmed: 19716372
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8815-9
pubmed: 24889614
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
pubmed: 18503082
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):E2083-90
pubmed: 22745174
Clin Transl Immunology. 2016 Jul 22;5(7):e93
pubmed: 27525066
Annu Rev Immunol. 2016 May 20;34:635-59
pubmed: 27168247
Cell. 2016 Apr 7;165(2):449-63
pubmed: 26949186
Nat Med. 2015 Jan;21(1):86-91
pubmed: 25501908
PLoS One. 2011;6(8):e22365
pubmed: 21829618
Sci Transl Med. 2014 Jul 2;6(243):243ra88
pubmed: 24990883
Elife. 2018 Nov 07;7:
pubmed: 30403372
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4743-4748
pubmed: 29666227
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
Immunity. 2018 Apr 17;48(4):799-811.e9
pubmed: 29669253
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Cold Spring Harb Protoc. 2011 Jun 01;2011(6):695-715
pubmed: 21632778
J Mol Biol. 2013 Apr 26;425(8):1302-17
pubmed: 23274142
J Virol. 2015 Dec 30;90(6):2806-17
pubmed: 26719252
Elife. 2018 Nov 09;7:
pubmed: 30412051
Immunity. 2018 Jan 16;48(1):133-146.e6
pubmed: 29287996
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Science. 2014 Dec 12;346(6215):1380-1383
pubmed: 25504724
J Virol. 2015 Apr;89(8):4201-13
pubmed: 25631091
Nat Med. 2014 Mar;20(3):296-300
pubmed: 24509526
PLoS Pathog. 2015 Oct 30;11(10):e1005238
pubmed: 26516768
Nature. 2010 Sep 30;467(7315):591-5
pubmed: 20882016
PLoS Pathog. 2018 Nov 5;14(11):e1007431
pubmed: 30395637
Immunity. 2018 Dec 18;49(6):1162-1174.e8
pubmed: 30552024
J Exp Med. 2013 Apr 8;210(4):655-63
pubmed: 23530120
Immunity. 2013 Aug 22;39(2):245-58
pubmed: 23911655
J Exp Med. 2014 Sep 22;211(10):2061-74
pubmed: 25155019
J Struct Biol. 2003 Jun;142(3):334-47
pubmed: 12781660
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
Science. 2015 Jul 10;349(6244):156-61
pubmed: 26089355
Nature. 2013 Jul 4;499(7456):102-6
pubmed: 23698367
Nature. 2016 May 5;533(7601):105-109
pubmed: 27120156
Science. 2010 Aug 13;329(5993):811-7
pubmed: 20616231
Nature. 2014 May 1;509(7498):55-62
pubmed: 24590074
Nat Commun. 2016 Feb 24;7:10618
pubmed: 26907590
Cell. 2016 Sep 8;166(6):1445-1458.e12
pubmed: 27610569
Nature. 2013 Apr 25;496(7446):469-76
pubmed: 23552890
J Synchrotron Radiat. 2004 Jan 1;11(Pt 1):53-5
pubmed: 14646133
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
Immunity. 2019 Jul 16;51(1):141-154.e6
pubmed: 31315032
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

K Rachael Parks (KR)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA.

Anna J MacCamy (AJ)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Josephine Trichka (J)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Matthew Gray (M)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Connor Weidle (C)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Andrew J Borst (AJ)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Arineh Khechaduri (A)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Brittany Takushi (B)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Parul Agrawal (P)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Javier Guenaga (J)

IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, CA, USA.

Richard T Wyatt (RT)

IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, CA, USA.

Rhea Coler (R)

Department of Global Health, University of Washington, Seattle, WA, USA; Infectious Disease Research Institute, Seattle, WA, USA.

Michael Seaman (M)

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Celia LaBranche (C)

Laboratory for AIDS Vaccine Research and Development, Duke University, Durham, NC, USA.

David C Montefiori (DC)

Laboratory for AIDS Vaccine Research and Development, Duke University, Durham, NC, USA.

David Veesler (D)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Marie Pancera (M)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA. Electronic address: mpancera@fredhutch.org.

Andrew McGuire (A)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: amcguire@fredhutch.org.

Leonidas Stamatatos (L)

Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: lstamata@fredhutch.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH